Aptalis Pharma Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 15

  • Investments
  • 6

Aptalis Pharma General Information

Description

Manufacturer of pharmaceutical products intended for the treatment of gastrointestinal diseases. The company offers therapies for cystic fibrosis and gastrointestinal disorders, as well as pharmaceutical products for exocrine pancreatic insufficiency, enabling patients to get proper medication for their health problems conveniently.

Contact Information

Formerly Known As
Axcan Intermediate Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 100 Somerset Corporate Boulevard
  • Suite 2000
  • Bridgewater, NJ 08807
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 100 Somerset Corporate Boulevard
  • Suite 2000
  • Bridgewater, NJ 08807
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aptalis Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aptalis Pharma‘s full profile, request access.

Request a free trial

Aptalis Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended for the treatment of gastrointestinal diseases. The company offers ther
Pharmaceuticals
Bridgewater, NJ
1,000 As of 2014

Bresso, Italy
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aptalis Pharma Competitors (85)

One of Aptalis Pharma’s 85 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The Zambon Group Private Debt Financed Bresso, Italy
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Chiesi Farmaceutici Private Debt Financed Parma, Italy
Evoke Pharma Formerly VC-backed Solana Beach, CA
Mirum Pharmaceuticals Formerly VC-backed Foster City, CA
You’re viewing 5 of 85 competitors. Get the full list »

Aptalis Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aptalis Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aptalis Pharma‘s full profile, request access.

Request a free trial

Aptalis Pharma Investments & Acquisitions (6)

Aptalis Pharma’s most recent deal was a Buyout/LBO with Mpex Pharmaceuticals for . The deal was made on 01-Jul-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mpex Pharmaceuticals 01-Jul-2011 Buyout/LBO Pharmaceuticals
Eurand 11-Feb-2011 Buyout/LBO Pharmaceuticals
Laboratoires Enteris 07-Nov-2001 Merger/Acquisition Distributors (Healthcare)
Scandipharm 10-Sep-1999 Merger/Acquisition Pharmaceuticals
Bonne Sante 31-Aug-1999 Merger/Acquisition Consulting Services (B2B)
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Aptalis Pharma Exits (2)

Aptalis Pharma’s most recent exit was on 31-Aug-1999 from Bonne Sante. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Bonne Sante 31-Aug-1999 Completed
Althin Biopharm 19-Dec-1995 Joint Venture Completed
  • 2 buyers
To view Aptalis Pharma’s complete exits history, request access »

Aptalis Pharma FAQs

  • When was Aptalis Pharma founded?

    Aptalis Pharma was founded in 1982.

  • Where is Aptalis Pharma headquartered?

    Aptalis Pharma is headquartered in Bridgewater, NJ.

  • What is the size of Aptalis Pharma?

    Aptalis Pharma has 1,000 total employees.

  • What industry is Aptalis Pharma in?

    Aptalis Pharma’s primary industry is Pharmaceuticals.

  • Is Aptalis Pharma a private or public company?

    Aptalis Pharma is a Private company.

  • What is the current valuation of Aptalis Pharma?

    The current valuation of Aptalis Pharma is .

  • What is Aptalis Pharma’s current revenue?

    The current revenue for Aptalis Pharma is .

  • How much funding has Aptalis Pharma raised over time?

    Aptalis Pharma has raised $1.12B.

  • Who are Aptalis Pharma’s investors?

    Aisling Capital, Alberta Investment Management, Fonds de solidarite FTQ, Graycliff Partners, and La Caisse are 5 of 13 investors who have invested in Aptalis Pharma.

  • Who are Aptalis Pharma’s competitors?

    The Zambon Group, Dicerna Pharmaceuticals, Chiesi Farmaceutici, Evoke Pharma, and Mirum Pharmaceuticals are some of the 85 competitors of Aptalis Pharma.

  • When was Aptalis Pharma acquired?

    Aptalis Pharma was acquired on 06-Feb-2014.

  • Who acquired Aptalis Pharma?

    Aptalis Pharma was acquired by Forest Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process